Claim · model-written summary
Acridocarpus monodii is used to treat malaria, reported by 71.10% of respondents.
- Taxon
- Acridocarpus monodiiAcridocarpus monodiit0
- Outcome
- malariae0
- Value
- 71.10%e0
Verbatim
t0“Acridocarpus monodii Arène & Jaeger”
e0“A. monodii is used to treat a dozen pathologies or diseases, dominated by malaria (71.10%), yellow fever (24.40%) and dysuria (20%)”
Title
Mamadou A. Konaré; Joudy Dougnon; Issiaka Togola; et al. Scientific Reports 2024. doi:10.1038/s41598-024-78405-3
Other claims from this paper (15)
- Observation Acridocarpus monodii is used to treat yellow fever, reported by 24.40% of respondents.
- Observation Acridocarpus monodii is used to treat dysuria, reported by 20% of respondents.
- Observation Leaves were the most coveted plant part for use (88.90%).
- Observation Roots were the next most coveted plant part for use (37.80%).
- Association Use of plant parts was significantly associated with the educational level of respondents.
- Observation Medicinal recipes were mostly prepared as decoctions.
- Observation Recipes were administered by oral route in 100% of cases.
- Observation Recipes were administered by bath in 82.20% of cases.
- Observation Acridocarpus monodii extracts contained a high quantity of flavonoids and polyphenols.
- Observation Acridocarpus monodii extracts showed increased in vitro antioxidant inhibitory effects.
- Observation Decoction extracts had the highest phenolic compound content (109.82 mg GAE/g).
- Observation The decoction had the strongest DPPH radical scavenging with IC50 of 107.41 µg/mL.
- Observation The hydroethanolic macerate had the strongest DPPH radical scavenging with IC50 of 107.31 µg/mL.
- Association The hydroethanolic macerate had higher antioxidant capacity (42.85 mg EQ/g) than the decoction.
- Recommendation A. monodii is a promising species for the discovery of novel medicines.